Sectra AB (publ) (SECT-B.ST)
SEK 274.3
(0.94%)
SEK 274.3
(0.94%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.64 Billion SEK | 13.98% |
| 2022 | 1.43 Billion SEK | 29.59% |
| 2021 | 1.11 Billion SEK | 46.92% |
| 2020 | 756.32 Million SEK | 8.88% |
| 2019 | 694.63 Million SEK | 18.35% |
| 2018 | 586.9 Million SEK | -6.6% |
| 2017 | 628.41 Million SEK | 3.37% |
| 2016 | 607.94 Million SEK | 9.1% |
| 2015 | 557.24 Million SEK | 16.57% |
| 2014 | 478.03 Million SEK | 20.61% |
| 2013 | 396.33 Million SEK | -5.24% |
| 2012 | 418.25 Million SEK | 20.65% |
| 2011 | 346.68 Million SEK | -4.81% |
| 2010 | 364.18 Million SEK | -0.52% |
| 2009 | 366.1 Million SEK | -10.5% |
| 2008 | 409.04 Million SEK | -3.82% |
| 2007 | 425.27 Million SEK | 26.93% |
| 2006 | 335.05 Million SEK | -1.18% |
| 2005 | 339.07 Million SEK | 26.02% |
| 2004 | 269.07 Million SEK | 9.13% |
| 2003 | 246.55 Million SEK | -7.47% |
| 2002 | 266.45 Million SEK | 35.31% |
| 2001 | 196.92 Million SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.51 Billion SEK | -7.53% |
| 2023 Q1 | 1.34 Billion SEK | -6.82% |
| 2023 Q4 | 1.64 Billion SEK | 14.65% |
| 2023 Q3 | 1.43 Billion SEK | 5.79% |
| 2023 Q2 | 1.35 Billion SEK | 0.85% |
| 2023 FY | 1.64 Billion SEK | 13.98% |
| 2022 Q3 | 1.12 Billion SEK | 15.68% |
| 2022 FY | 1.43 Billion SEK | 29.59% |
| 2022 Q2 | 971.72 Million SEK | 3.04% |
| 2022 Q1 | 943.09 Million SEK | -15.13% |
| 2022 Q4 | 1.43 Billion SEK | 28.1% |
| 2021 Q1 | 660.35 Million SEK | -12.69% |
| 2021 Q2 | 654.01 Million SEK | -0.96% |
| 2021 Q3 | 869.2 Million SEK | 32.9% |
| 2021 Q4 | 1.11 Billion SEK | 27.84% |
| 2021 FY | 1.11 Billion SEK | 46.92% |
| 2020 FY | 756.32 Million SEK | 8.88% |
| 2020 Q1 | 582.21 Million SEK | -16.18% |
| 2020 Q3 | 710.72 Million SEK | 22.12% |
| 2020 Q2 | 582 Million SEK | -0.04% |
| 2020 Q4 | 756.32 Million SEK | 6.42% |
| 2019 Q3 | 689.86 Million SEK | 10.54% |
| 2019 Q2 | 624.07 Million SEK | 8.2% |
| 2019 Q1 | 576.77 Million SEK | -1.73% |
| 2019 FY | 694.63 Million SEK | 18.35% |
| 2019 Q4 | 694.63 Million SEK | 0.69% |
| 2018 Q1 | 586.5 Million SEK | -6.67% |
| 2018 Q3 | 595.02 Million SEK | -4.44% |
| 2018 Q4 | 586.9 Million SEK | -1.36% |
| 2018 FY | 586.9 Million SEK | -6.6% |
| 2018 Q2 | 622.67 Million SEK | 6.17% |
| 2017 Q1 | 582.76 Million SEK | -4.14% |
| 2017 FY | 628.41 Million SEK | 3.37% |
| 2017 Q3 | 577.1 Million SEK | -2.25% |
| 2017 Q2 | 590.41 Million SEK | 1.31% |
| 2017 Q4 | 628.41 Million SEK | 8.89% |
| 2016 Q1 | 519.25 Million SEK | -6.82% |
| 2016 FY | 607.94 Million SEK | 9.1% |
| 2016 Q3 | 578.09 Million SEK | 8.55% |
| 2016 Q2 | 532.56 Million SEK | 2.56% |
| 2016 Q4 | 607.94 Million SEK | 5.16% |
| 2015 Q3 | 524.9 Million SEK | 21.34% |
| 2015 Q2 | 432.58 Million SEK | 1.18% |
| 2015 Q1 | 427.55 Million SEK | -10.56% |
| 2015 Q4 | 557.24 Million SEK | 6.16% |
| 2015 FY | 557.24 Million SEK | 16.57% |
| 2014 Q4 | 478.03 Million SEK | 10.21% |
| 2014 Q3 | 433.74 Million SEK | 8.48% |
| 2014 Q2 | 399.84 Million SEK | 15.55% |
| 2014 Q1 | 346.04 Million SEK | -12.69% |
| 2014 FY | 478.03 Million SEK | 20.61% |
| 2013 Q4 | 396.33 Million SEK | -3.81% |
| 2013 Q1 | 360.47 Million SEK | -13.82% |
| 2013 Q2 | 364.81 Million SEK | 1.21% |
| 2013 Q3 | 412.05 Million SEK | 12.95% |
| 2013 FY | 396.33 Million SEK | -5.24% |
| 2012 Q1 | 322.55 Million SEK | -6.96% |
| 2012 Q3 | 360.77 Million SEK | 5.03% |
| 2012 Q4 | 418.25 Million SEK | 15.93% |
| 2012 FY | 418.25 Million SEK | 20.65% |
| 2012 Q2 | 343.49 Million SEK | 6.49% |
| 2011 Q2 | 307.01 Million SEK | -4.52% |
| 2011 Q1 | 321.54 Million SEK | -11.71% |
| 2011 FY | 346.68 Million SEK | -4.81% |
| 2011 Q4 | 346.68 Million SEK | -0.6% |
| 2011 Q3 | 348.78 Million SEK | 13.6% |
| 2010 Q4 | 364.18 Million SEK | 9.18% |
| 2010 FY | 364.18 Million SEK | -0.52% |
| 2010 Q3 | 333.55 Million SEK | -2.03% |
| 2010 Q1 | 329.77 Million SEK | -9.93% |
| 2010 Q2 | 340.48 Million SEK | 3.25% |
| 2009 Q4 | 366.1 Million SEK | 0.0% |
| 2009 FY | 366.1 Million SEK | -10.5% |
| 2008 FY | 409.04 Million SEK | -3.82% |
| 2007 FY | 425.27 Million SEK | 26.93% |
| 2006 FY | 335.05 Million SEK | -1.18% |
| 2005 FY | 339.07 Million SEK | 26.02% |
| 2004 FY | 269.07 Million SEK | 9.13% |
| 2003 FY | 246.55 Million SEK | -7.47% |
| 2002 FY | 266.45 Million SEK | 35.31% |
| 2001 FY | 196.92 Million SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acarix AB (publ) | 10.99 Million SEK | -14824.05% |
| ADDvise Group AB (publ) | 2.67 Billion SEK | 38.623% |
| ADDvise Group AB (publ) | 2.67 Billion SEK | 38.623% |
| Arcoma AB | 33.3 Million SEK | -4828.23% |
| Bactiguard Holding AB (publ) | 329.7 Million SEK | -397.83% |
| BICO Group AB (publ) | 3.26 Billion SEK | 49.723% |
| Boule Diagnostics AB (publ) | 279.9 Million SEK | -486.405% |
| CellaVision AB (publ) | 212.32 Million SEK | -673.042% |
| Clinical Laserthermia Systems AB (publ) | 14.19 Million SEK | -11461.224% |
| Chordate Medical Holding AB (publ) | 6.86 Million SEK | -23795.204% |
| C-Rad AB (publ) | 122.4 Million SEK | -1240.97% |
| Duearity AB (publ) | 17.53 Million SEK | -9263.075% |
| Dignitana AB (publ) | 37.56 Million SEK | -4269.119% |
| Episurf Medical AB (publ) | 19.8 Million SEK | -8189.631% |
| Getinge AB (publ) | 24.69 Billion SEK | 93.354% |
| Scandinavian Real Heart AB (Publ) | 20.6 Million SEK | -7867.586% |
| Iconovo AB (publ) | 14.55 Million SEK | -11177.718% |
| Integrum AB (publ) | 22.07 Million SEK | -7336.041% |
| Luxbright AB (publ) | 7 Million SEK | -23347.412% |
| Mentice AB (publ) | 163.55 Million SEK | -903.551% |
| OssDsign AB (publ) | 105.25 Million SEK | -1459.371% |
| Paxman AB (publ) | 44.5 Million SEK | -3587.674% |
| Promimic AB (publ) | 16.15 Million SEK | -10059.366% |
| Qlife Holding AB (publ) | 62.16 Million SEK | -2540.137% |
| SciBase Holding AB (publ) | 21.27 Million SEK | -7613.822% |
| ScandiDos AB (publ) | 37.18 Million SEK | -4313.884% |
| Sedana Medical AB (publ) | 44.06 Million SEK | -3625.085% |
| Senzime AB (publ) | 58.06 Million SEK | -2726.741% |
| SpectraCure AB (publ) | 14.97 Million SEK | -10860.581% |
| Stille AB | 172.64 Million SEK | -850.734% |
| Vitrolife AB (publ) | 3.66 Billion SEK | 55.252% |
| Xvivo Perfusion AB (publ) | 250.56 Million SEK | -555.056% |